Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

With an expected 333,830 new cases in 2026, prostate cancer remains the most common malignancy in men in the United States.  ...

Prostate cancer diagnoses are rising even as treatments improve — and researchers still don’t know why. Uncovering the cause could transform prevention and care for millions. The American Cancer ...

Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive ...

A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The study, the largest of its kind, recruited 7,500 men from eastern, southern ...

Scientists have discovered vital clues to help predict, more than a decade in advance, which men may develop prostate cancer.

Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...

The prostate is a walnut-sized organ that sits behind your penis. Its purpose is to help make semen. It usually gets larger with age. Sometimes as the prostate gets larger with age, cancer cells form ...

A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The study, the largest of its kind, recruited 7,500 men from eastern, southern ...